Human genetic studies reported that a single-nucleotide polymorphism (SNP) in IL-33 is associated with increased risk for the late-onset form of Alzheimer’s disease (Chapuis et al., 2009; Yu et al., 2012). This evidence concerns the gene IL33 and Alzheimer disease.